Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 443 results for "erbitux"

Human medicines European public assessment report (EPAR): Er...

Erbitux : EPAR - Procedural steps taken and scientific information after authorisation HR = Hrvatski 2009-07-14 2014-08-14 ... European Medicines Agency, 2 weeks ago

2 images for "erbitux"

Drug Discovery and Development, 4 weeks ago
Pharma Letter, 1 month ago
Scottrade

Alchemia Announces First Patient Enrolled in Investigator-Led Phase II Trial of HA-Irinotecan and Erbitux (CHIME Trial)

"The commencement of this clinical trial achieves another milestone in the clinical development of HA-Irinotecan as this study will be the first use of a HyACT drug within an antibody-containing regimen, which is the current and future standard of ...
 Noodls2 months ago ALCHEMIA : Announces First Patient Enrolled in Investigator-Led Phase II Trial of HA-Irinotecan and Erbitux ("CHIME" Trial)  4 Traders2 months ago Alchemia Appoints Jenni Pilcher as Chief Financial Officer  Fat Pitch Financials3 days ago ALCHEMIA : Appoints Jenni Pilcher as Chief Financial Officer  4 Traders3 days ago
[x]  

Gilotrif combined with Erbitux Benefits Non-Small Cell Lung Cancer Patients Resistant to EGFR Inhibitors

Researchers recently reported that a combination of the epidermal growth factor receptor (EGFR) targeted agents Gilotrif® (afatinib) and Erbitux® (cetuximab) were able to effectively shrink EGFR positive non-small cell lung (NSCLC)cancer that had ...
 CancerConnect.com3 weeks ago New treatment combination benefited patients with lung cancer resistant to EGFR inhibitors  Ecancer Medicalscience1 month ago New Treatment Combination Benefits Patients With EGFR Inhibitors  Advance for Respiratory Care & Sleep Medicine1 month ago Afatinib plus cetuximab shows promise for EGFR -mutated lung cancer  Orthopedics Today4 weeks ago
Pharma Letter

Erbitux equal to Avastin in colorectal cancer survival, FIRE-3 study shows30-06-2014

Merck Serono, the biotech subsidiary of Germany's Merck KGaA (MRK: DE), has released positive new clinical trial results comparing its cancer drug Erbitux (cetuximab) with Swiss drug major Roche's (ROG: SIX) blockbuster Avastin (bevacizumab). ...
 Pharma Letter1 month ago From biopsies to blood-based testing  Drug Discovery News1 month ago

ESMO: Erbitux No Help in Esophageal Ca (CME/CE)

Gastroenterology Published: Jul 2, 2014 | Updated: Jul 2, 2014 Reviewedby Zalman S. Agus, MD ; Emeritus Professor, Perelman School of Medicine at the University of Pennsylvania Survival in esophageal cancer did not improve with the addition of ...
 MedPage Today1 month ago

Chemotherapy Regimens paired with Avastin or Erbitux Extended Survival for Patients with Metastatic Colorectal Cancer

In a plenary session of the American Society of Clinical Oncology (ASCO) meeting in Chicago, researchers reported that treatment of metastatic colorectal cancer with Avastin® (bevacizumab) or Erbitux® (cetuximab) and standard chemotherapy (FOLFOX ...
 CancerConnect.com2 months ago

Colorectal cancer therapies market to remain constant at $7.7 billion by 2023

Decision Resources Group finds that the market for colorectal cancer (CRC) therapies will remain constant, at around $7.7 billion by 2023 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. The biosimilar erosion of ...
 News-Medical.Net6 hours ago The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies  Vision Monday16 hours ago
[x]  

Truncated epiderimal growth factor receptor (EGFRt) for transduced T cell selection

A non-immunogenic selection epitope may be generated by removing certain amino acid sequences of the protein. For example, a gene encoding a truncated human epidermal growth factor receptor polypeptide (EGFRt) that lacks the membrane distal ...
 PharmCast6 hours ago
Ecancer Medicalscience

FOLFIRI Plus Cetuximab vs Bevacizumab for Some Colorectal Cancers

Reuters Health Information By Scott Baltic August28,2014 NEW YORK (Reuters Health) - In patients with KRAS exon 2 wild-type metastatic colorectal cancer (MCC) who received first-line FOLFIRI (fluorouracil, folinic acid and irinotecan), adding ...
 American Journal of Public Health15 hours ago No difference in response rate but overall survival benefit with first-line FOLFIRI/cetuximab versus FOLFIRI/bevacizumab in metastic colocrectal cancer  Ecancer Medicalscience2 weeks ago
Asian Scientist

MERCK KGAA : acute;s Biopharmaceutical Division Announces Groundbreaking of New Pharmaceutical Manufacturing Facility in China, its Second Largest Worldwide

News Release Your Contact Bénédicte Bogh Phone +41 79 500 0137 August 27, 2014 Merck KGaA´s Biopharmaceutical Division Announces Groundbreaking of New Pharmaceutical Manufacturing Facility in China, its Second Largest Worldwide • ...
 4 Traders1 day ago Merck Serono Announces Groundbreaking of New Pharmaceutical Manufacturing Facility in China, its Second Largest Worldwide  Individual.com1 day ago Merck To Open Second Largest Plant In China  Asian Scientist3 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less